OF
Omega Fund Management, LLC
Boston MA · SEC CIK 0001637359
$185.69M2026Q2 reported value
10Positions
100.0%Top 10 weight · largest 29.1%
0 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
No buys this quarter
2026Q2 top sells estimated at quarter-end value
BCAX Reduced-$16.92M
REPL Sold out-$1.91M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | $54.10M | 29.14% | 1,822,150 | -570,000 | -23.8% | -$16.92M | Reduced |
| NUVB | Nuvation Bio Inc. | $45.90M | 24.72% | 8,081,089 | 0 | 0.0% | — | Unchanged |
| KMTS | Kestra Med Technologies Ltd | $26.00M | 14.00% | 1,022,149 | 0 | 0.0% | — | Unchanged |
| BBOT | BridgeBio Oncology Therapeutics Inc. | $25.07M | 13.50% | 3,289,661 | 0 | 0.0% | — | Unchanged |
| BBNX | Beta Bionics Inc. | $20.62M | 11.11% | 1,316,183 | 0 | 0.0% | — | Unchanged |
| ALMS | Alumis Inc. | $6.79M | 3.66% | 241,255 | 0 | 0.0% | — | Unchanged |
| SANA | Sana Biotechnology, Inc. | $2.94M | 1.59% | 843,750 | 0 | 0.0% | — | Unchanged |
| — | ImageneBio, Inc. | $2.69M | 1.45% | 455,361 | 0 | 0.0% | — | Unchanged |
| — | enGene Holdings Inc. | $1.52M | 0.82% | 876,357 | 0 | 0.0% | — | Reappeared |
| ODTX | Odyssey Therapeutics Inc. | $54,128 | 0.03% | 2,893 | 2,893 | — | — | First reported |
| REPL | Replimune Group | $0 | 0.00% | 0 | -248,672 | -100.0% | -$1.91M | Sold out |